Table 1.
Distribution of Sociodemographic and Clinical Characteristics Among Women (n = 2,313) in the Cardiovascular Health Study Sample by Quintiles of Body Mass Index at Baseline, United States, 1989–1990 or 1992–1993
| Characteristic | BMI, kg/m2 |
||||||||||||||
| <22.5 |
22.5–24.7 |
24.8–27.0 |
27.1–30.3 |
≥30.4 |
|||||||||||
| Mean (SD) | % | Median (IQR) | Mean (SD) | % | Median (IQR) | Mean (SD) | % | Median (IQR) | Mean (SD) | % | Median (IQR) | Mean (SD) | % | Median (IQR) | |
| Age, years | 73.1 (5.8) | 71.8 (5.1) | 72.0 (5.0) | 71.7 (5.1) | 71.3 (4.7) | ||||||||||
| Black | 5.6 | 10.6 | 10.8 | 18.8 | 27.1 | ||||||||||
| Education | |||||||||||||||
| Less than high school | 19.2 | 24.2 | 21.4 | 27.4 | 36.8 | ||||||||||
| High school graduate | 30.7 | 32.6 | 32.0 | 30.9 | 30.1 | ||||||||||
| College or higher | 50.1 | 43.2 | 46.5 | 41.7 | 33.1 | ||||||||||
| Smoking status | |||||||||||||||
| Never | 56.2 | 51.8 | 58.0 | 57.2 | 60.6 | ||||||||||
| Former | 26.8 | 30.9 | 31.8 | 35.0 | 30.3 | ||||||||||
| Current | 17.1 | 17.3 | 10.2 | 7.8 | 9.1 | ||||||||||
| Alcoholic drinks/week | |||||||||||||||
| 0 | 48.2 | 48.0 | 47.6 | 53.6 | 67.3 | ||||||||||
| <7 | 36.7 | 36.1 | 40.3 | 40.6 | 29.4 | ||||||||||
| 7–13 | 7.1 | 6.7 | 5.6 | 2.8 | 1.7 | ||||||||||
| ≥14 | 8.0 | 9.3 | 6.5 | 3.0 | 1.5 | ||||||||||
| Self-reported health | |||||||||||||||
| Excellent | 18.4 | 19.4 | 16.7 | 14.5 | 9.6 | ||||||||||
| Very good | 31.5 | 28.5 | 29.0 | 28.6 | 20.4 | ||||||||||
| Good | 32.3 | 37.4 | 39.6 | 37.7 | 41.1 | ||||||||||
| Fair | 15.6 | 14.0 | 13.6 | 17.5 | 25.7 | ||||||||||
| Poor | 2.2 | 0.7 | 1.1 | 1.7 | 3.3 | ||||||||||
| Weight change from age 50 years, kg | −2.2 (5.6) | 1.5 (5.7) | 3.5 (6.1) | 6.2 (7.3) | 13.2 (10.9) | ||||||||||
| Physical activity, kcal | 600 (135–1,335) | 540 (120–1,350) | 504 (113–1,240) | 405 (23–1,170) | 263 (0–840) | ||||||||||
| Estrogen use | |||||||||||||||
| Never | 59.6 | 53.1 | 59.5 | 62.0 | 66.0 | ||||||||||
| Past | 24.2 | 29.8 | 25.3 | 25.7 | 26.8 | ||||||||||
| Current | 16.2 | 17.1 | 15.2 | 12.3 | 7.1 | ||||||||||
| Aspirin use >2 days in past 2 weeks | 25.7 | 24.6 | 29.4 | 26.1 | 28.8 | ||||||||||
| Systolic blood pressure, mm Hg | 132.6 (22.2) | 134.2 (21.9) | 135.8 (22.2) | 137.7 (21.2) | 139.2 (20.8) | ||||||||||
| Diastolic blood pressure, mm Hg | 68.2 (10.9) | 68.9 (10.4) | 69.9 (11.2) | 70.6 (11.1) | 72.4 (10.6) | ||||||||||
| Hypertension | 41.7 | 49.8 | 58.2 | 62.6 | 70.6 | ||||||||||
| Use of antihypertensive medication | 27.4 | 34.3 | 38.7 | 45.8 | 53.7 | ||||||||||
| Impaired fasting glucose | 24.0 | 26.4 | 36.4 | 41.0 | 45.7 | ||||||||||
| Diabetes | 4.5 | 6.3 | 10.0 | 13.8 | 23.2 | ||||||||||
| Glucose, mg/dL | 97.4 (20.7) | 99.6 (18.8) | 105.1 (26.7) | 111.5 (42.6) | 121.4 (49.3) | ||||||||||
| Insulin, IU/mL | 10.9 (9.5) | 12.3 (10.6) | 14.8 (18.3) | 18.2 (29.2) | 22.1 (26.7) | ||||||||||
| Total cholesterol, mg/dL | 215.6 (36.0) | 222.2 (37.6) | 223.6 (38.7) | 224.3 (37.7) | 219.9 (38.9) | ||||||||||
| LDL cholesterol, mg/dL | 125.5 (34.5) | 134.0 (37.5) | 136.5 (37.1) | 138.8 (35.6) | 135.9 (35.4) | ||||||||||
| HDL cholesterol, mg/dL | 67.4 (17.8) | 63.1 (15.7) | 60.3 (15.6) | 56.6 (13.3) | 54.3 (12.9) | ||||||||||
| Triglycerides, mg/dL | 100 (82–129) | 110 (86–152) | 123 (96–162) | 129 (10–175) | 135 (102–180) | ||||||||||
| Serum creatinine, mg/dL | 0.89 (0.21) | 0.92 (0.25) | 0.91 (0.20) | 0.92 (0.21) | 0.94 (0.24) | ||||||||||
| hsCRP, mg/L | 1.5 (0.7–2.9) | 1.9 (0.9–3.5) | 2.6 (1.3–2.6) | 3.0 (1.9–4.8) | 3.9 (2.5–8.6) | ||||||||||
Abbreviations: BMI, body mass index; HDL, high density lipoprotein; hsCRP, high-sensitivity C-reactive protein; IQR, interquartile range; LDL, low density lipoprotein; SD, standard deviation.